Do you want to read an article? Please log in or register.
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Further Publications
Related content
Cardiovascular Risk and DiseasesFurther Publications
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial
JAMA Cardiol
Johansen ND, Modin D, Loiacono MM, Harris RC, Dufournet M, Larsen CS, Larsen L, Wiese L, Dalager-Pedersen M, Claggett BL, Janstrup KH, Bartholdy KV, Bernholm KF, Borchsenius JIH, Davidovski FS, Davodian LW, Dons M, Duus LS, Espersen C, Fussing FH, Jensen AMR, Landler NE, Langhoff ACF, Lassen MCH, Nielsen AB, Ottosen CI, Sengeløv M, Skaarup KG, Pareek M, Solomon SD, Landray MJ, Gislason GH, Køber L, Sivapalan P, Martel CJ, Jensen JUS, Biering-Sørensen T
doi: 10.1001/jamacardio.2025.3460
Cardiovascular Risk and Diseases
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
Lancet
Deanfield J, Lincoff AM, Kahn SE, Emerson SS, Lingvay I, Scirica BM, Plutzky J, Kushner RF, Colhoun HM, Hovingh GK, Stensen S, Weeke PE, Jeppesen OK, Bravo R, Wu CC, Komuro I, Santini F, Hjelmesæth J, Urina-Triana M, Buscemi S, Ryan DH
doi: 10.1016/S0140-6736(25)01375-3
Cardiovascular Risk and Diseases
Cardiovascular Hospitalizations Among Older Adults in the US and Denmark
JAMA Cardiol
Berg FH, Lassen MCH, Vaduganathan M, Fonarow GC, Yeh RW, Zheng Z, Gislason GH, Biering-Sørensen T, Wadhera RK
doi: 10.1001/jamacardio.2024.5303
Cardiovascular Risk and Diseases
Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0-3: The GOLD-Health cohort
Diabetes Res Clin Pract
Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, Zhou Q, Zhuang Z, Luo L, Fang Y, Liu X, Burroughs T, McMillin SE, Lin H, Zhang Z, Chen G
doi: 10.1016/j.diabres.2025.112327
Hypertension
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis
Eur Heart J
Zhang DY, An DW, Yu YL, Melgarejo JD, Boggia J, Martens DS, Hansen TW, Asayama K, Ohkubo T, Stolarz-Skrzypek K, Malyutina S, Casiglia E, Lind L, Maestre GE, Wang JG, Imai Y, Kawecka-Jaszcz K, Sandoya E, Rajzer M, Nawrot TS, O'Brien E, Yang WY, Filipovský J, Graciani A, Banegas JR, Li Y, Staessen JA, International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators
doi: 10.1093/eurheartj/ehaf220
COMMENTED
Cardiovascular Risk and Diseases
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB, SOUL Study Group
doi: 10.1056/NEJMoa2501006
Cardiovascular Risk and Diseases
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Lancet Diabetes Endocrinol
Aggarwal R, Bhatt DL, Szarek M, Cannon CP, Leiter LA, Inzucchi SE, Lopes RD, McGuire DK, Lewis JB, Riddle MC, Davies MJ, Banks P, Carroll AK, Scirica BM, Ray KK, Kosiborod MN, Cherney DZI, Udell JA, Verma S, Mason RP, Pitt B, Steg PG
doi: 10.1016/S2213-8587(24)00362-0
Heart, Artery and Coronary Diseases
Preoperative Cardiovascular Risk and Postoperative Outcomes by Renin-Angiotensin System Inhibitor Use: A Secondary Analysis of a Randomized Clinical Trial
JAMA Cardiol
Tang J, Pirracchio R, Cholley B, Joosten A, Birckener J, Falcone J, Charbonneau H, Delaporte A, Chen D, Gayat E, Legrand M
doi: 10.1001/jamacardio.2025.1920
Heart Failure
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials
JACC Heart Fail
Lassen MCH, Ostrominski JW, Claggett BL, Neuen BL, Beldhuis IE, Butt J, Biering-Sørensen T, Desai AS, Lewis EF, Jhund PS, Mc Causland F, Anand IS, Pfeffer MA, Pitt B, Zannad F, Zile MR, McMurray JJV, Solomon SD, Vaduganathan M
doi: 10.1016/j.jchf.2025.03.042